-
-
Eisai’s Efforts on Global Health
-
Fostering the Next Generation Leaders in Global Health
Attending as a Judge in “Policy Pitch”, a Policy Proposal Event by Gen Z
-
An Event for Japanese Media and Next-Generation Leaders in Global Health to Meet Patients with Lymphatic Filariasis
-
-
September 28, 2023
-
September 28, 2023
TOKIO MARINE NICHIDO AND EISAI
CO-DEVELP INDUSTRY’S FIRST “DEMENTIA CARE SUPPORT INSURANCE” -
September 25, 2023
-
September 22, 2023
-
September 21, 2023
-
August 25, 2023
-
August 17, 2023
-
August 3, 2023
-
August 2, 2023
IR “First Quarter Financial Report for the Fiscal Year Ending March 31, 2024”
-
July 21, 2023
IR "Alzheimer’s Association International Conference (AAIC) [Material]"
-
March 9, 2023
Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties
-
February 17, 2023
EISAI SUPPORTS RELIEF EFFORTS FOR EARTHQUAKE IN TURKEY AND SYRIA
-
July 15, 2022
Notification Regarding U.S. Research and Development Subsidiary
-
April 1, 2022
-
November 24, 2021
Sustainability
29 countries 2.13 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of June 2023)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
